these multiple patents applications make one wonder where PYC will be in 10 years. At one drug per year ( as they are capable of) 10 drugs seems possible moving towards $$( in addition to the 4 now) and 4 through trials to revenue makes one wonder when the platform will be recognised as our major asset.
I guess it will hinge off number one success but no missteps and proving the drugs work in vitro, using small doses (thanks to the delivery system) hence avoiding side effects all mean the success rate is much higher than the market expects or values us at.
A small move up in price suggests tax loss selling is done, and some are building a stake.
PYC Price at posting:
$1.29 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)